Granulocyte-monocyte Apheresis in Ulcerative Colitis

Last updated: June 14, 2017
Sponsor: Valduce Hospital
Overall Status: Completed

Phase

N/A

Condition

Crohn's Disease

Ulcers

Ulcerative Colitis

Treatment

N/A

Clinical Study ID

NCT03189888
5/2012
  • All Genders

Study Summary

BACKGROUND: Granulocyte-monocyte apheresis has been proposed for the treatment of ulcerative colitis, although is limited by costs and variability of results.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • moderate UC with steroid-dependence and azathioprine intolerance or resistance

Study Design

Total Participants: 33
Study Start date:
January 01, 2013
Estimated Completion Date:
December 31, 2013